Skip to content

Clinical trials

Phase 2/3 trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Czechia Clear all

155 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20042
20054
200610
20074
20085
20094
20104
20113
20128
20134
20146
20156
20167
20171
20189
20198
20205
202112
202212
20237
202410
202512
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Recruiting29
Terminated26
Active, not recruiting18
Unknown status4
Enrolling by invitation4
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer12
Bristol-Myers Squibb7
Janssen Research & Development, LLC7
Novartis Pharmaceuticals6
AstraZeneca5
Sanofi4
Boehringer Ingelheim3
CSL Behring3
argenx3
AB Science2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative7
COVID-195
Crohn Disease4
Diabetes Mellitus3
Macular Degeneration3
Myelodysplastic Syndromes3
Neoplasm Metastasis3
Recurrence3
Squamous Cell Carcinoma of Head and Neck3
Stomach Neoplasms3

Trials

Showing 26 to 50 of 155. Each trial links to its page on Pharma Observatory.

55 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.